期刊文献+

脱细胞异种骨对星形胶质细胞的影响 被引量:1

Effects of xenogeneic acellular bone on the astrocyte cells
下载PDF
导出
摘要 目的探讨脱细胞异种骨对星形胶质细胞增殖、迁移及细胞特性的影响。方法采用环氧交联技术制备脱细胞异种骨,将不同浸提浓度(0.05、0.1、0.2 g/mL)的异种骨浸提液加入含星形胶质细胞的培养基中。扫描电镜观察细胞形态;MTT法检测细胞增殖情况,确定最佳浸提浓度;Transwell小室检测细胞迁移情况;流式细胞仪检测细胞周期。结果扫描电镜示星形胶质细胞生长状态良好,呈星状结构;不同浸提浓度的异种骨浸提液中,0.05 g/mL的浸提液对细胞增殖有促进作用,0.05 g/mL为最佳浸提浓度;经该浸提浓度异种骨浸提液处理的细胞,迁移数量明显增多(P<0.05),但细胞各周期比例无明显变化(P>0.05)。结论经脱细胞脱基质处理的异种骨,对神经胶质细胞无明显毒性,对星形胶质细胞具有良好的细胞相容性。 Objective To observe the effects of xenogeneic acellular bone on the proliferation , migration and characteristic of astrocyte cells .Methods The xenogeneic bone was prepared by epoxy crosslinking technology after chemical and physical processing .Different concentrations (0.05, 0.1, 0.2 g/mL) of xenogeneic bone extracted liquid were added into the culture mediums with astrocyte cells .Scanning electron microscope ( SEM) was used for morphologic observation of astrocyte cells .MTT method was used detect the proliferation of the astrocyte cells , and to optimize the con-centration of xenogeneic bone extracted liquid .Transwell method and flow cytometry were used to access the cell migration and cell cycle , respectively .Results The astrocyte cells were polygonal , and were in a good state under SEM .The opti-mized concentration of xenogeneic bone extracted liquid was 0.05 g/mL, which had a positive effect on cell proliferation . In this concentration , the number of transwell cells was increased ( P〈0.05) , with no alteration on the cell cycle ( P〉0.05).Conclusion Xenogeneic acellular bone has low influence on astrocyte cells , providing good biosecurity to astro-cyte cells.
出处 《广东医学》 CAS CSCD 北大核心 2014年第10期1470-1472,共3页 Guangdong Medical Journal
基金 国家自然科学基金资助项目(编号:81272057 81271957) 再生型医用植入器械国家工程实验室PI项目(编号:2012NELRMD007)
关键词 异种骨 星形胶质细胞 细胞迁移 细胞周期 生物安全性 xenogeneic bone astrocyte cells cell migration cell cycle biosecurity
  • 相关文献

参考文献14

  • 1BAUER T W. Bone graft substitutes[J]. Skeletal Radio1, 2007, 36(12) :1105 - 1107.
  • 2URABE K, ITOMAN M, TOYAMA Y, et al. Current trends in hone grafting and the issue of banked bone allografts based on the fourth nationwide survey of bone grafting status from 2000 to 2004 [J]. J Orthop Sci, 2007, 12(6) : 520-525.
  • 3邱贵兴,孙世荃.同种异体骨植入材料的临床应用[J].中华骨科杂志,2004,24(10):635-637. 被引量:66
  • 4PIERSON R N. Primate T - eel1 responses to porcine antigens: implications for clinical xenotransplantation[J].Xenotransplantation, 2006, 13(1) : 14-18.
  • 5BOLANO L, KOPTA J A. The immunology of bone and cartilage transplantation[J].Orthodpedics, 1991, 14(9): 987-996.
  • 6夏胜利,杨庆秋,胡侦明,劳汉昌.复合异种骨研究进展[J].中国矫形外科杂志,2003,11(9):622-623. 被引量:2
  • 7邓小华,刘晟,蔡维君,雷德亮,罗学港.LPS诱导小鼠脑星形胶质细胞激活及Bcl-2表达的变化[J].中南大学学报(医学版),2007,32(3):401-407. 被引量:3
  • 8RIDET J L, MALHOTRA S K, PRIVAT A, et al. Reactive astrocytes: cellular and molecular cues to biological function [ J]. Trends Neuresci, 1997, 20(12) : 570-577.
  • 9WIESELER FRANK J, MAIER S F, WATKINS L R. Glial acti- vation and pathological pain[ J ]. Neurechem Int, 2004, 45 ( 2/ 3) : 389 - 395.
  • 10张恒,周占松,刘丽梅,杨忠,宋波.P物质对脊髓星形胶质细胞活化和炎性因子IL-1β、TNF-α分泌的影响[J].第三军医大学学报,2006,28(7):681-684. 被引量:18

二级参考文献79

共引文献113

同被引文献15

  • 1游晓青,林玲,胡建石,郑志竑.bFGF、BMP-2、ATRA对神经干细胞分化及RARα mRNA表达的影响[J].中华神经外科杂志,2005,21(8):504-508. 被引量:8
  • 2BAUER T W. Bone graft substitutes[ J]. Skeletal Radiol, 2007, 36(12) : 1105 -1107.
  • 3PIERSON R N. Primate T - cell responses to porcine antigens: implications for clinical xenotransplantation [ J ]. Xenotransplanta- tion, 2006, 13(1) : 14 -18.
  • 4BOLANO L, KOPTA J A. The immunology of bone and cartilage transplantation[J]. Orthopedics, 1991, 14(9):987-996.
  • 5HENCH L L, POLAK J M. Third -generation biomedical materi- als[J]. Science, 2002, 295(5557) : 1014 - 1017.
  • 6MCKAY R. Stem ceils in the central nervous system[ J]. Science, 1997, 276(5309) : 66 -71.
  • 7GAO A, PENG Y, DENG Y, et al. Potential therapeutic applica- tions of differentiated induced pluripotent stem cells ( iPSCs ) in the treatment of neurodegenerative diseases [ J ]. Neuroscience, 2013, 228 : 47 - 59.
  • 8SHARPE M E, MORTON D, ROSSI A. Nonclinical safety strate- gies for stem cell therapies [ J]. Toxicol Appl Pharmacol, 2012, 262(3) : 223 -231.
  • 9REEKMANS K, PRAET J, DAANS J, et al. Current challenges for the advancement of neural stem cell biology and transplantation research[J]. Stem Cell Rev, 2012, 8(1) : 262 -278.
  • 10LIU J, GOTHERSTROM C, FORSBERG M, et al. Human neural stem/progenitor cells derived from embryonic stem cells and fetal nervous system present differences in immunogenicity and immuno- modulatory potentials in vitro[ J]. Stem Cell Res, 2013, 10 (3) : 325 - 337.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部